The pharmaceutical firm will establish a research innovation hub in California, and manufacturing facilities in Florida, Texas, Indiana, and New Jersey.

European drugmaker Novartis (NVS), best known for blockbuster drugs like Entresto, Cosentyx, and Kesimpta, just announced a ...

Swiss pharmaceutical giant Novartis announced it will spend $23 billion to build and expand 10 facilities in the United ...

Swiss pharmaceutical giant Novartis announced Thursday that it plans to build a $1.1 billion research hub in San Diego as part of its $23 billion investment in U.S. operations over the next five years ...

Novartis plans to spend $23 billion over the next five years to expand its manufacturing, research and technology presence in the U.S.

Investment is expected to bring approximately 1,000 new jobs at Novartis and 4,000 additional roles across the United States.

It has been a choppy week for European and global markets as investors have been reacting to the frequent developments in ...

Swiss pharmaceutical company, Novartis, has announced plans to build a new, $1.1 billion biomedical research complex in San ...

Swiss drugmaker Novartis said on Thursday it plans to spend $23 billion to build and expand 10 facilities in the U.S., as it grapples with renewed threats of drug import duties from the Trump ...

The Swiss pharmaceutical giant plans to build seven new facilities and expand others in an effort that will allow it to ...

Novartis expects the new capacity will allow it to produce all of its key medicines “end to end” in the U.S., as the Trump ...

Novartis plans new manufacturing sites and a second R&D hub as it shifts key operations to the US.